CUV 1.15% $15.44 clinuvel pharmaceuticals limited

Ann: CEO Letter to Shareholders, page-18

  1. 792 Posts.
    lightbulb Created with Sketch. 1027

    Is CUV going broke? Nope, no debt, $160 Million cash and next year will deliver NPAT ~$35-40 Million in my opinion. That would be an EPS approaching 0.8 AUD. Now the funny part, DISC medicine has a lead product targeting the EPP market (at least ~5 years away) which Clinuvel already monopolises while DISC only burns cash, they don't print cash like CUV, yet DISC has a market cap close to 2 BILLION AUD, around 3 Times greater than CUV!

    Google Clinuvel Bulletin May 2023 then read page 2, DISC has nothing like these ambitions either.

    "We already know we have a market leading product; the next step is to create a globally recognised brand. We are unflinching in our ambition to increase brand equity and to realise our bold aim to make CLINUVEL a household name by 2026. (And a name on the lips of the most influential beauty editors and taste-makers long before that!)."

    Lets see if they can deliver. Share buyback now.

    All IMO DYOR


 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.44
Change
-0.180(1.15%)
Mkt cap ! $773.2M
Open High Low Value Volume
$15.60 $15.75 $15.39 $751.4K 48.47K

Buyers (Bids)

No. Vol. Price($)
1 173 $15.40
 

Sellers (Offers)

Price($) Vol. No.
$15.54 209 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.